Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $63.58.
A number of research analysts have recently issued reports on TEM shares. Morgan Stanley boosted their target price on Tempus AI from $60.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, May 9th. Bank of America boosted their target price on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a report on Wednesday. Piper Sandler boosted their target price on Tempus AI from $55.00 to $70.00 and gave the company a “neutral” rating in a report on Thursday, May 15th. Needham & Company LLC reissued a “buy” rating and issued a $70.00 target price on shares of Tempus AI in a report on Wednesday, May 7th. Finally, BTIG Research started coverage on Tempus AI in a report on Monday, April 21st. They issued a “buy” rating and a $60.00 target price on the stock.
Get Our Latest Report on Tempus AI
Insider Buying and Selling
Institutional Trading of Tempus AI
Large investors have recently bought and sold shares of the company. Victory Capital Management Inc. acquired a new stake in Tempus AI in the fourth quarter valued at $216,000. Wells Fargo & Company MN grew its holdings in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares during the last quarter. SeaCrest Wealth Management LLC acquired a new stake in Tempus AI in the first quarter valued at $535,000. ProShare Advisors LLC acquired a new stake in Tempus AI in the fourth quarter valued at $244,000. Finally, Avanza Fonder AB lifted its position in shares of Tempus AI by 15.8% in the first quarter. Avanza Fonder AB now owns 41,005 shares of the company’s stock valued at $2,047,000 after acquiring an additional 5,591 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.
Tempus AI Price Performance
Shares of NASDAQ TEM opened at $68.34 on Tuesday. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. Tempus AI has a twelve month low of $27.68 and a twelve month high of $91.45. The stock has a 50 day moving average of $60.74 and a two-hundred day moving average of $53.15. The stock has a market cap of $11.83 billion and a P/E ratio of -8.76.
Tempus AI (NASDAQ:TEM – Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business’s revenue was up 75.4% on a year-over-year basis. On average, research analysts forecast that Tempus AI will post -6.15 earnings per share for the current year.
Tempus AI Company Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
- Five stocks we like better than Tempus AI
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is IBM’s AI Transformation Powering a Sustained Rally?
- 3 REITs to Buy and Hold for the Long Term
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.